L-dopa related hyperhomocysteinemia and development of dementia in Parkinson's disease

被引：0
|
作者：
dell'Aquila, C.
Zoccolella, S.
Mascolo, L.
Abruzzese, G.
Antonini, A.
Bonuccelli, U.
Dlazio, G.
Pacchetti, C.
Lamberti, P.
机构：
来源：
MOVEMENT DISORDERS | 2008年 / 23卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
760
引用
收藏
页码：S249 / S249
页数：1
相关论文
共 50 条
  • [21] L-DOPA and cortical associative plasticity in Parkinson's disease
    Suppa, Antonio
    Bologna, Matteo
    Berardelli, Alfredo
    CLINICAL NEUROPHYSIOLOGY, 2013, 124 (04) : 638 - 639
  • [22] THE L-DOPA RESPONSE IN PATHOLOGICALLY CONFIRMED PARKINSON'S DISEASE
    Pitz, Vanessa
    Malek, Naveed
    Grosset, Katherine A.
    Grosset, Donald G.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2018, 89 (10):
  • [23] Paradoxical response to L-dopa and apomorphine in the Parkinson's disease
    García-Soldevilla, MA
    Puertas, I
    Barcenilla, B
    Sayed, Y
    García-Albea, E
    Jiménez-Jiménez, FJ
    MOVEMENT DISORDERS, 2002, 17 : S96 - S96
  • [24] Parkinson's disease, L-DOPA, and endogenous morphine: A revisit
    Stefano, George B.
    Mantione, Kirk J.
    Kralickova, Milena
    Ptacek, Radek
    Kuzelova, Hana
    Esch, Tobias
    Kream, Richard M.
    MEDICAL SCIENCE MONITOR, 2012, 18 (08): : RA133 - RA137
  • [25] L-DOPA for Parkinson's disease-a bittersweet pill
    Lane, Emma L.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 384 - 398
  • [26] L-DOPA: A scapegoat for accelerated neurodegeneration in Parkinson's disease?
    Lipski, Janusz
    Nistico, Robert
    Berretta, Nicola
    Guatteo, Ezia
    Bernardi, Giorgio
    Mercuri, Nicola B.
    PROGRESS IN NEUROBIOLOGY, 2011, 94 (04) : 389 - 407
  • [27] Parkinson's disease: Progression and mortality in the L-DOPA era
    DiRocco, A
    Molinari, SP
    Kollmeier, B
    Yahr, MD
    PARKINSON'S DISEASE, 1996, 69 : 3 - 11
  • [28] L-dopa impairs associative learning in Parkinson's disease
    Shohamy, D
    Myers, CE
    Onlaor, S
    Gluck, MA
    JOURNAL OF COGNITIVE NEUROSCIENCE, 2002, : 84 - 84
  • [29] Dementia and hyperhomocysteinemia in Parkinson's disease
    Menendez, M.
    Ribacoba, R.
    Jimenez, G.
    Virgili, J. R.
    Huerta, C.
    De la Vega, V.
    MOVEMENT DISORDERS, 2007, 22 : S188 - S188
  • [30] Oral L-dopa solution therapy of menstrual-related fluctuations in Parkinson's disease
    García-Moreno, JM
    Páramo, L
    Chacón, J
    PARKINSONISM & RELATED DISORDERS, 2003, 10 (01) : 53 - 54
12345